Amplification of c-myc Oncogene by Chromogenic and Fluorescence In Situ Hybridization in Archival Breast Cancer Tissue Array Samples
Open Access
- 1 November 2001
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 81 (11) , 1545-1551
- https://doi.org/10.1038/labinvest.3780368
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Amplification of c-myc by Fluorescence In Situ Hybridization in a Population-Based Breast Cancer Tissue ArrayLaboratory Investigation, 2001
- Discrepancies in Clinical Laboratory Testing of Eligibility for Trastuzumab Therapy: Apparent Immunohistochemical False-Positives Do Not Get the MessageJournal of Clinical Oncology, 2001
- Chromogenic in Situ HybridizationThe American Journal of Pathology, 2000
- Sensitivity and Detection Efficiency of a Novel Two-Step Detection System (PowerVision) for ImmunohistochemistryApplied Immunohistochemistry & Molecular Morphology, 1999
- MYC oncogenes and human neoplastic diseaseOncogene, 1999
- Subtracted, Unique-Sequence, In Situ HybridizationThe American Journal of Pathology, 1998
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Evaluation ofMYC and chromosome 8 copy number in breast carcinoma by interphase cytogeneticsGenes, Chromosomes and Cancer, 1997
- ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.Proceedings of the National Academy of Sciences, 1992
- Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.Proceedings of the National Academy of Sciences, 1986